Interpace Diagnostics Announces European Patent Approval For Underlying Technology of its ThyraMIR® microRNA ... - Yahoo Finance

Interpace Diagnostics Announces European Patent Approval For Underlying Technology of its ThyraMIR® microRNA ... Yahoo Finance According to the American Cancer Society, thyroid cancer is one of the most rapidly increasing cancers in the US tripling in the past three decades. Most physicians have traditionally recommended thyroid surgery where thyroid nodule biopsy results are ... and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oQwoFY
via IFTTT